Huajian Medical and Renhe International reach cooperation to jointly build a vertical RWA trading platform focused on the over-the-counter drug sector
Jinse Finance reported that Huajian Medical, a Hong Kong-listed company, has issued an announcement stating that the group has reached a strategic cooperation with Renhe International, a wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd. Together, they will jointly establish a vertical RWA trading platform in the United States focused on the over-the-counter drug sector. (Zhitong Finance)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yesterday, the net inflow of the US Solana spot ETF was $15.7 million.

Grayscale applies to convert Sui Trust into an ETF, plans to list and trade on NYSE Arca
BitMine purchases another 22,676 ETH, worth approximately $68.67 million
